American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edn., text rev. 2022. Washington, DC: American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425787.

GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137–50. https://doi.org/10.1016/S2215-0366(21)00395-3.

Article  Google Scholar 

Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10(1):99. https://doi.org/10.1186/1741-7015-10-99.

Article  Google Scholar 

Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005. https://doi.org/10.1136/ADC.2004.059006.

Article  Google Scholar 

Faraone SV, Schachar RJ, Barkley RA, Nullmeier R, Sallee FR. Early morning functional impairments in stimulant-treated children with attention-deficit/hyperactivity disorder versus controls: impact on the family. J Child Adolesc Psychopharmacol. 2017;27(8):715–22. https://doi.org/10.1089/cap.2016.0164.

Article  CAS  Google Scholar 

Barkley RA, Cunningham CE. The effects of methylphenidate on the mother-child interactions of hyperactive children. Arch Gen Psychiatry. 1979;36(2):201–8. https://doi.org/10.1001/ARCHPSYC.1979.01780020091010.

Article  CAS  Google Scholar 

Sallee FR. Early morning functioning in stimulant-treated children and adolescents with attention-deficit/hyperactivity disorder, and its impact on caregivers. J Child Adolesc Psychopharmacol. 2015;25(7):558–65. https://doi.org/10.1089/cap.2014.0160.

Article  Google Scholar 

Epstein JN, Weiss MD. Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review. Prim Care Companion CNS Disord. 2012;14(6):PCC.11r01336. https://doi.org/10.4088/PCC.11R01336.

Article  Google Scholar 

CADDRA-Canadian ADHD Resource Alliance. Canadian ADHD practice guidelines. 4.1. Toronto: CADDRA; 2020.

Google Scholar 

Coghill D, Soutullo C, d’Aubuisson C, Preuss U, Lindback T, Silverberg M, et al. Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health. 2008;2(1):31. https://doi.org/10.1186/1753-2000-2-31.

Article  Google Scholar 

Whalen CK, Henker B, Jamner LD, Ishikawa SS, Floro JN, Swindle R, et al. Toward mapping daily challenges of living with ADHD: maternal and child perspectives using electronic diaries. J Abnorm Child Psychol. 2006;34(1):111–26. https://doi.org/10.1007/s10802-005-9008-5.

Article  Google Scholar 

Faraone SV, Childress A, Wigal SB, Kollins SH, McDonnell MA, DeSousa NJ, et al. Reliability and validity of the Daily Parent Rating of Evening and Morning Behavior Scale. Revised J Atten Disord. 2015;22(11):1066–73. https://doi.org/10.1177/1087054715619009.

Article  Google Scholar 

Faraone SV, Hammerness PG, Wilens TE. Reliability and validity of the before-school functioning scale in children with ADHD. J Atten Disord. 2015;22(11):1040–8. https://doi.org/10.1177/1087054714564623.

Article  Google Scholar 

Faraone SV, DeSousa NJ, Komolova M, Sallee FR, Incledon B, Wilens TE. Functional impairment in youth With ADHD: normative data and norm-referenced cutoff points for the Before School Functioning Questionnaire and the Parent Rating of Evening and Morning Behavior Scale. Revised J Clin Psychiatry. 2019. https://doi.org/10.4088/JCP.19M12956.

Article  Google Scholar 

Breuer D, Görtz-Dorten A, Rothenberger A, Döpfner M. Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings. Eur Child Adolesc Psychiatry. 2011;20(Suppl. 2):289–96. https://doi.org/10.1007/s00787-011-0206-0.

Article  Google Scholar 

Wilens TE, McBurnett K, Turnbow J, Rugino T, White C, Youcha S. Morning and evening effects of guanfacine extended release adjunctive to psychostimulants in pediatric ADHD. J Atten Disord. 2016;21(2):110–9. https://doi.org/10.1177/1087054713500144.

Article  Google Scholar 

Wilens TE, Hammerness P, Martelon M, Brodziak K, Utzinger L, Wong P. A controlled trial of the methylphenidate transdermal system on before-school functioning in children With attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010;71(05):548–56. https://doi.org/10.4088/jcp.09m05779pur.

Article  CAS  Google Scholar 

Wehmeier PM, Dittmann RW, Schacht A, Helsberg K, Lehmkuhl G. Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies. Child Adolesc Psychiatry Ment Health. 2009;3(1):5. https://doi.org/10.1186/1753-2000-3-5.

Article  Google Scholar 

Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345–65. https://doi.org/10.1111/jcpp.12381.

Article  Google Scholar 

Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. https://doi.org/10.1097/CHI.0B013E318054E724.

Article  Google Scholar 

Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4): e20192528. https://doi.org/10.1542/peds.2019-2528.

Article  Google Scholar 

Döpfner M, Görtz-Dorten A, Breuer D, Rothenberger A. An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety. Eur Child Adolesc Psychiatry. 2011;20(Suppl. 2):243–55. https://doi.org/10.1007/s00787-011-0202-4.

Article  Google Scholar 

Kollins SH, Braeckman R, Guenther S, Barrett AC, Mickle TC, Oh C, et al. A randomized, controlled laboratory classroom study of serdexmethylphenidate and d-methylphenidate capsules in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2021;31(9):597–609. https://doi.org/10.1089/CAP.2021.0077.

Article  CAS  Google Scholar 

Highlights of prescribing information. Jornay PM® (methylphenidate hydrochloride) extended-release capsules for oral use, CII. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209311s008lbl.pdf. Accessed 20 Sep 2021.

Childress AC, Cutler AJ, Marraffino A, McDonnell MA, Turnbow JM, Brams M, et al. A randomized, double-blind, placebo-controlled study of HLD200, a delayed-release and extended-release methylphenidate, in children with attention-deficit/hyperactivity disorder: an evaluation of safety and efficacy throughout the day and across settings. J Child Adolesc Psychopharmacol. 2020;30(1):2–14. https://doi.org/10.1089/cap.2019.0070.

Article  CAS  Google Scholar 

Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, et al. Efficacy and safety of HLD200, delayed-release and extended-release methylphenidate, in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2017;27(6):474–82. https://doi.org/10.1089/cap.2017.0084.

Article  CAS  Google Scholar 

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004;114(1):e1-8. https://doi.org/10.1542/peds.114.1.e1.

Article  Google Scholar 

Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep. 2006;29(12):1573–85. https://doi.org/10.1093/sleep/29.12.1573.

Article  Google Scholar 

Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002;159(11):1896–901. https://doi.org/10.1176/APPI.AJP.159.11.1896.

Article  Google Scholar 

Sasser T, Schoenfelder EN, Stein MA. Targeting functional impairments in the treatment of children and adolescents with ADHD. CNS Drugs. 2017;31(2):97–107. https://doi.org/10.1007/S40263-016-0400-1.

Article  Google Scholar 

Wilens TE, Faraone SV, Hammerness PG, Pliszka SR, Uchida CL, DeSousa NJ, et al. Clinically meaningful improvements in early morning and late afternoon/evening functional impairment in children with ADHD treated with delayed-release and extended-release methylphenidate. J Atten Disord. 2022;26(5):696–705. https://doi.org/10.1177/10870547211020073.

Article  Google Scholar 

Childress AC, Cutler AJ, Po MD, DeSousa NJ, Warrington LE, Sallee FR, et al. Symptomatic and functional response and remission from the open-label treatment-optimization phase of a study with DR/ER-MPH in children with ADHD. J Clin Psychiatry. 2021;82(4):21m13914. https://doi.org/10.4088/jcp.21m13914.

Article  Google Scholar 

Wilens TE, McBurnett K, Turnbow J, Rugino T, White C, Youcha S. Morning and evening effects of guanfacine extended release adjunctive to psychostimulants in pediatric ADHD. J Atten Disord. 2017;21(2):110–9. https://doi.org/10.1177/1087054713500144.

Article  Google Scholar